I agree that this site is using cookies. You can find further informations
here
.
X
Login
Merkliste (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
zur Desktop-Version
Toggle navigation
Merkliste
1 Ergebnisse
1
PRISMA 2009 checklist:
Karel H. van der Pol (11785133)
;
Kimberley E. Wever (10751753)
;
Mariette Verbakel (11785136)
...
https://figshare.com/articles/journal_contribution/PRISMA_2009_checklist_/17115605. , 2021
Link:
https://doi.org/10.1371/journal.pone.0260844.s008
RT Journal T1
PRISMA 2009 checklist
UL https://suche.suub.uni-bremen.de/peid=base-ftsmithonian:oai:figshare.com:article_17115605&Exemplar=1&LAN=DE A1 Karel H. van der Pol (11785133) A1 Kimberley E. Wever (10751753) A1 Mariette Verbakel (11785136) A1 Frank L. J. Visseren (8445648) A1 Jan H. Cornel (9322877) A1 Gerard A. Rongen (11785139) YR 2021 K1 Physiology K1 Pharmacology K1 Developmental Biology K1 Science Policy K1 serum urate concentration K1 original 1995 references K1 adequately powered randomized K1 achieved (& lt K1 randomized controlled trials K1 91 ] K1 p K1 80 ] K1 reduce cardiovascular morbidity K1 observational studies indicate K1 21 observational studies K1 15 observational studies K1 xlink "> pubmed K1 xlink "> data K1 significantly reduced risk K1 appropriate allopurinol dose K1 allopurinol group compared K1 rct &# 8217 K1 random effects meta K1 analysis </ p K1 reduced cardiovascular mortality K1 risk ratio 0 K1 observational studies K1 xlink "> K1 3 studies K1 controlled trial K1 cardiovascular mortality K1 cardiovascular events K1 cardiovascular benefit K1 allopurinol therapy K1 systematic review K1 sufficient reduction K1 significant effect K1 rr 0 K1 narrative synthesis K1 myocardial infarction K1 july 2020 K1 combined endpoint K1 combined end K1 cochrane library K1 36 mmol K1 300 mg JF https://figshare.com/articles/journal_contribution/PRISMA_2009_checklist_/17115605 LK http://dx.doi.org/https://doi.org/10.1371/journal.pone.0260844.s008 DO https://doi.org/10.1371/journal.pone.0260844.s008 SF ELIB - SuUB Bremen
Export
RefWorks (nur Desktop-Version!)
Flow
(Zuerst in
Flow
einloggen, dann importieren)